CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

NCT05218408 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No enrolled subjects

Conditions

Astrocytoma, Grade IV
Glioblastoma
Giant Cell Glioblastoma
Glioblastoma Multiforme

Interventions

BIOLOGICAL: CYNK-001 systemic and Intra cavity administration

Sponsor

Celularity Incorporated